United States - English - NLM (National Library of Medicine)

a-s medication solutions - neostigmine methylsulfate (unii: 98imh7m386) (neostigmine - unii:3982twq96g) - neostigmine methylsulfate injection is a cholinesterase inhibitor indicated for the reversal of the effects of non­ depolarizing neuromuscular blocking agents after surgery. neostigmine methylsulfate injection is contraindicated in patients with: • known hypersensitivity to neostigmine methylsulfate (known hypersensitivity reactions have included urticaria, angioedema, erythema multiforme, generalized rash, facial swelling, peripheral edema, pyrexia, flushing, hypotension, bronchospasm, bradycardia and anaphylaxis). • with peritonitis or mechanical obstruction of the intestinal or urinary tract. risk summary   there are no adequate or well-controlled studies of neostigmine methylsulfate injection in pregnant women. it is not known whether neostigmine methylsulfate injection can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. the incidence of malformations in human pregnancies has not been established for neostigmine as the data are limited. all pregnancies, regard

Canada - English - Health Canada

sterimax inc - neostigmine methylsulfate - solution - 0.5mg - neostigmine methylsulfate 0.5mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

sterimax inc - neostigmine methylsulfate - solution - 1mg - neostigmine methylsulfate 1mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

marcan pharmaceuticals inc - neostigmine methylsulfate - solution - 0.5mg - neostigmine methylsulfate 0.5mg - parasympathomemetic (cholinergic) agents

Canada - English - Health Canada

marcan pharmaceuticals inc - neostigmine methylsulfate - solution - 1mg - neostigmine methylsulfate 1mg - parasympathomemetic (cholinergic) agents

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - neostigmine methylsulfate, quantity: 2.5 mg; glycopyrronium bromide, quantity: 0.5 mg - injection, solution - excipient ingredients: water for injections; citric acid; dibasic sodium phosphate dodecahydrate; sodium hydroxide - reversal of residual non-depolarising (competitive) neuromuscular block.

Kenya - English - Pharmacy and Poisons Board

laboratoire renaudin za errobi 64250 itxassou france - neostigmine inj. 2.5mg/1ml - solution for injection - 1 ml of solution contains 2.5 mg of neostigmine… - parasympathomimetics: anticholinesterases

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorio sanderson s.a. - neostigmina metilsulfato - neostigmina metilsulfato....0.5 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vitalis s.a.c.i. - neostigmina metilsulfato - neostigmina metilsulfato....0.5 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios arsal, s.a. de c.v. - neostigmina metilsulfato - neostigmina metilsulfato....0.5 mg